ESSA Pharma Inc (EPIX)

5.70 -0.55 (-8.80%)
Close USD Disclaimer
5.98 +0.28 (+4.91%)

ESSA Pharma Inc Company Profile

Equity Type
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company’s lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Contact Information
Vancouver,V5Z 1K5 Canada
778 331 0962
Top Executives
Marianne D. Sadar 62 2009 Scientific Advisor
Franklin M. Berger 74 2015 Independent Director
Gary R. Sollis 70 2012 Independent Director
Marella Thorell 56 2019 Independent Director
Raymond Andersen 76 2009 Scientific Advisor
Philip W. Kantoff 68 2022 Independent Director
Richard M. Glickman 65 2010 Independent Chairman of the Board
Scott Requadt 55 2016 Independent Director
John Alexander Martin 55 2019 Independent Director
Sanford S. Zweifach 67 2019 Independent Director
Lauren Merendino 48 2023 Independent Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles